Delivery Order 75F40118D10022-75F40119F19002

Award Date 9/24/19
Potential Completion Date 9/23/20
Potential Value $5.6M
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative contract. The $9,854,162.67 time and materials contract is for the development of new and innovative methods for automated reporting for the FDA's Center for Biologics Evaluation and Research (CBER). The contract supports the BEST Initiative, which focuses on developing advanced methods for tracking and...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a $14,609,200.89 delivery order contract to International Business Machines Corporation (IBM) for the "DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGICAL PRODUCTS". This contract is a Time and Materials type under the BEST Initiative - New and Innovative Methods for Automated Reporting master IDIQ. The contract does not have a set-aside designation. IBM,...
This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) for the development of new and innovative methods for automated reporting for biological products regulated by the FDA's Center for Biologics Evaluation and Research (CBER). The contract has a potential value of $6,999,176.74 and is on a time and materials pricing basis. It was awarded under the BEST Initiative master...
This $7,464,141.78 contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to adapt to evolving HL7 standards and ensure continuity of operations as well as enabling enhancements at the FDA. The contract is a Blanket Purchase Agreement (BPA) call and utilizes a labor hours pricing type. As the prime contractor, IBM has engaged several subcontractors, including Accenture Federal Services, Eclaro International, Eight Eleven Group,...
This contract, awarded by the Food and Drug Administration (FDA), is for $254,956.19 to provide data management support services. The prime contractor is International Business Machines Corporation (IBM), a major federal IT services provider. The contract is a delivery order with a labor hours pricing type, and has no set-aside designation. IBM has secured numerous prime and subcontract awards from various agencies, including the Department of Health and Human Services, to provide services...
This is a time and materials delivery order contract awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM), a global technology company. The $552,098.41 contract is for regulatory review data standardization services, with a period of performance through September 28, 2017. The contract is not set aside for a specific business type. As a major federal contractor, IBM has secured numerous prime and subcontract awards from various government...
This federal contract award is for DATA STANDARDS TESTING AND IMPLEMENTATION services, with a ceiling value of $2,737,337.22. The contract was awarded to the prime contractor, International Business Machines Corporation (IBM), by the Food and Drug Administration (FDA), a civilian agency. The contract does not have a set-aside designation. The contract is a BPA (Blanket Purchase Agreement) call under the Regulatory Review Support Services master BPA. This indicates that the services being...
This federal contract award, with an ID of 75F40119A10019|75F40122F19025, was issued by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for $607,298.49 and was awarded to International Business Machines Corporation (IBM) to provide "ANALYSIS DATA STANDARDS SUPPORT DIGITAL HEALTH TECHNOLOGIES". It is a firm fixed price BPA call under IBM's existing Regulatory Review Support Services contract vehicle....
This is a delivery order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to International Business Machines Corporation (IBM) on August 27, 2015. The contract is a labor hours contract with a ceiling value of $2,418,193.90 and an ultimate completion date of September 13, 2016. The contract is not set aside. IBM is a global technology company that provides a wide range of hardware, software, cloud computing, artificial intelligence, and consulting services to the...
This contract, awarded by the Food and Drug Administration (FDA), is for clinical data safety analysis services. The contract has a ceiling value of $813,829.25 and was awarded to International Business Machines Corporation (IBM), a major federal contractor that provides a wide range of IT services and solutions to the government. The contract is a Blanket Purchase Agreement (BPA) call under the Regulatory Review Support Services BPA, allowing the FDA to efficiently procure IBM's expertise in...

This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the International Business Machines Corporation (IBM) on September 24, 2019. The $5,622,942.08 time and materials contract is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master IDIQ contract vehicle.

The objective is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics. This work does not have a set-aside designation. IBM has utilized small business subcontractors Eclaro International Inc. and Georgia Tech Applied Research Corporation to provide computer programming and IT services in support of the contract. The Medstar Health Research Institute and University of Florida have also served as subcontractors. The FDA's oversight of biologic product safety and efficacy aligns with its mission to protect and promote public health.

Generated 3/22/24, 6:07 PM